Ambeed.cn

首页 / 抑制剂/激动剂 / MAPK/ERK Pathway / MNK / CGP 57380

CGP 57380 {[allProObj[0].p_purity_real_show]}

货号:A151588 同义名: MNK1 Inhibitor

CGP 57380是一种选择性 Mnk1 抑制剂,IC50 值为 2.2 μM。

CGP 57380 化学结构 CAS号:522629-08-9
CGP 57380 化学结构
CAS号:522629-08-9
CGP 57380 3D分子结构
CAS号:522629-08-9
CGP 57380 化学结构 CAS号:522629-08-9
CGP 57380 3D分子结构 CAS号:522629-08-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

CGP 57380 纯度/质量文件 产品仅供科研

货号:A151588 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 MNK1 MNK2 其他靶点 纯度
CGP 57380 ++

MNK1, IC50: 2.2 μM

99%+
Tomivosertib +++

MNK1, IC50: 2.4 nM

++++

MNK2, IC50: 1 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

CGP 57380 生物活性

靶点
  • MNK1

    MNK1, IC50:2.2 μM

描述 MNK1 is important for its regulation of phosphorylation of eIF4E mediated via the activation of MAP kinase pathways. CGP57380 is a MNK1 inhibitor with IC50 values of 2.2μM and 3μM for inhibition of MNK1 kinase activity in vitro and phosphorylation of eIF4E in cellular assays, respectively. Pretreatment with CGP57380 at concentration of 10μM for 60min could block phosphorylation of eIF4E induced by TNF-α, arsenite, anisomycin, PMA or FCS in 293 cells. Meanwhile, inhibition of MNK1 by CGP-57380 resulted in a dose-dependent increase in the activity of cap-dependent translation in a reporter gene assay with reduced eIF4E phosphorylation in 293 cells. CGP57380 at concentration ranging in 1-10μM resulted in dose-dependent decreases in Ang II–stimulated phosphorylation of eIF4E, protein synthesis, and VSMC hypertrophy of VSMCs. CGP-57380 prevented eIF4E phosphorylation, β-catenin activation, and BC LSC function in vitro at concentration of 10μM and in vivo at dose of 40mg/kg, intraperitoneally, daily, for 3 weeks.

CGP 57380 细胞实验

Cell Line
Concentration Treated Time Description References
NP69 273.44 µM 72 h Low toxicity to normal cells Theranostics. 2017 May 30;7(7):2134-2149.
HNE1 103.278 µM 72 h Inhibition of cell proliferation and colony formation ability Theranostics. 2017 May 30;7(7):2134-2149.
CNE1 38.261 µM 72 h Inhibition of cell proliferation and colony formation ability Theranostics. 2017 May 30;7(7):2134-2149.
U87MG-luc cells 10 μM 3 days MTT assay showed that combined treatment with CGP57380 and RAD001 significantly inhibited cell proliferation. J Clin Invest. 2014 Feb;124(2):742-54.
LN229 cells 10 μM 20 h Western blot analysis showed that CGP57380 or MNK1 siRNA combined with RAD001 significantly inhibited 4EBP1 phosphorylation at Ser65. J Clin Invest. 2014 Feb;124(2):742-54.
U373 cells 10 μM 20 h Analyzed how MNK1 and mTORC1 signaling pathways regulate the assembly of translation initiation complexes, found that CGP57380 or MNK1 knockdown combined with RAD001 increased 4EBP1 binding to eIF4E. J Clin Invest. 2014 Feb;124(2):742-54.
CEM cells 4-16 μM 24 h CGP57380 dose-dependently suppressed the expression of both phosphor-MNK1 and phosphor-eIF4E, thereby inhibiting downstream targets such as c-Myc and survivin. Acta Pharmacol Sin. 2018 Dec;39(12):1894-1901.
Jurkat cells 4-16 μM 24 h CGP57380 dose-dependently suppressed the expression of both phosphor-MNK1 and phosphor-eIF4E, thereby inhibiting downstream targets such as c-Myc and survivin. Acta Pharmacol Sin. 2018 Dec;39(12):1894-1901.
A549 cells 20 μM CGP57380 substantially reduced eIF4G in the eIF4F complex while drastically inhibiting eIF4E phosphorylation Neoplasia. 2010 Oct;12(10):848-55.
H157 cells 10-40 μM 30 min pretreatment followed by 4 h co-treatment CGP57380 reduced basal p-eIF4E levels and almost completely blocked OA-induced increase in eIF4E phosphorylation Neoplasia. 2010 Oct;12(10):848-55.

CGP 57380 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Orthotopic GBM mouse model I.p. injection 25 mg/kg 4 injections between days 8 and 15 after implantation Evaluated the effects of CGP57380 alone or in combination with RAD001 in vivo, found that combined treatment significantly inhibited tumor growth. J Clin Invest. 2014 Feb;124(2):742-54.
BALB/c nude mice Subcutaneous tumor model Intraperitoneal injection 25 mg/kg Three times per week for 3 weeks Inhibition of tumor growth and metastasis Theranostics. 2017 May 30;7(7):2134-2149.
C57BL/6 mice LPS-induced acute lung injury model Intraperitoneal injection 30 mg/kg Single dose, pretreated for 30 min before LPS challenge To evaluate the protective effect of CGP57380 on LPS-induced acute lung injury. Results showed that CGP57380 pretreatment significantly attenuated LPS-induced lung wetry ratio, protein content, total cells and neutrophils in BALF, and decreased the production of pro-inflammatory mediators such as IL-6, TNF-α, and KC. Biochem Pharmacol. 2021 Apr;186:114499
Sprague-Dawley rats Experimental model of brain stem death Bilateral microinjection into RVLM 5 pmol Single administration, observed for 180 minutes To evaluate the effect of CGP57380 on cardiovascular regulation in the brain stem death model. Results showed that CGP57380 pretreatment exacerbated hypotension and blunted the life signal, shortening the pro-life phase. J Biomed Sci. 2010 Mar 15;17(1):17

CGP 57380 动物研究

Dose Mice: 20 mg/kg, 50 mg/kg[3] (i.p.)
Administration i.p.

CGP 57380 参考文献

[1]Chrestensen CA, Eschenroeder A,et al. Loss of MNK function sensitizes fibroblasts to serum-withdrawal induced apoptosis. Genes Cells. 2007 Oct;12(10):1133-40.

[2]Ishida M, Ishida T, et al. Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells. Circ Res. 2003 Dec 12;93(12):1218-24.

CGP 57380 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.09mL

0.82mL

0.41mL

20.47mL

4.09mL

2.05mL

40.95mL

8.19mL

4.09mL

CGP 57380 技术信息

CAS号522629-08-9
分子式C11H9FN6
分子量 244.23
SMILES Code NC1=C2C(NN=C2NC3=CC=C(F)C=C3)=NC=N1
MDL No. MFCD03861062
别名 MNK1 Inhibitor
运输蓝冰
InChI Key UQPMANVRZYYQMD-UHFFFAOYSA-N
Pubchem ID 11644425
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 5 mg/mL(20.47 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。